The Conversation (0)
BacTech Environmental Corporation (CNSX:BAC) has completed the 5-month biotech phase of testing of the Snow Lake concentrates.
As quoted in the press release:
In January 2012, BacTech was in Snow Lake to conduct a public consultation with the citizens of the community. Ross Orr, President and CEO provided an overview of the proposed project followed by a technical presentation by Dr. Paul Miller. Also in attendance were Mary Ann Mihychuk, Director of BacTech, Dave Salari, COO of BacTech and a representative of Newalta Corporation. A healthy and positive question and answer session followed the formal presentation.
Following the meeting, an alternate site for the proposed Snow Lake plant was identified that will lead to a significant reduction in the costs associated with material handling for delivery of material to the plant for processing. The acquisition of the proposed property is underway.
Click here to read the BacTech Environmental Corporation (CNSX:BAC) press release
Click here to see the BacTech Environmental Corporation (CNSX:BAC) profile.